Use access key #2 to skip to page content.
$63.81 0.24 (0.38%)
8/21/2008 4:00 PM

Amgen, Inc. (AMGN)

CAPS Rating:
****

A biotechnology company whcih discovers, develops, manufactures and markets human therapeutics based on advances in cellular and molecular biology.

View All Commentary (AMGN)

Recs

2

Avatar sleepyseth (99.09) Submitted: 11/03/06 3:05 PM : Outperform Start Price: $74.57 AMGN Score: -7.85

This is without a doubt the strongest biotech player. I beleive that they have been profitable longer than any other biotech ever and they offer as much of a saftey net as many of the well established pharmaceutical companies. The pipeline looks great, which is really the most important factor for valuation. Lets just hope that they can deliver on our high expectations.

Report this Post Replies: 0 | Reply

Featured Broker Partners